Selank Peptide Explained: Anxiety Research and Status (Philippines)

In Russia, it is an approved anti-anxiety drug. It started as a fragment of an immune protein. Here is what the research on Selank actually shows. Selank is a synthetic chain of seven amino acids.

It is built on tuftsin, a tiny four amino acid piece of the antibody protein immunoglobulin G, with three more amino acids added for stability. Like Semax, it came from the Institute of Molecular Genetics in Moscow. How might it work? Animal research points to the GABA system, the brain's main calming network.

A 2016 rat study found Selank changed the activity of dozens of genes involved in GABA signalling. In humans, a 2008 Russian clinical study in patients with generalized anxiety disorder and neurasthenia compared Selank with the benzodiazepine medazepam. Researchers reported similar anxiety reduction, without the sedation seen with the benzodiazepine. The limits matter.

Most human studies are small, Russian, and published in Russian. No large Western randomized trials exist, and long-term safety data is limited. In 2009, Selank was registered by Russia's Ministry of Health and approved for medical use. It is not approved by the US FDA.

Research-grade vials are not approved medicines. If you are sourcing research peptides in the Philippines, Primara Labs publishes independent lab reports you can verify yourself. Guides at primaralabs.com.